Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 69301-69350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05868902
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
N/ARecruiting
300 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05857761
GAIN Symptoms: Post-traumatic Headache
NAActive, not recruiting
62 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2027
3 conditions3 sponsors1 location
NCT06238609
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
NAActive, not recruiting
25 participants
Started: Aug 28, 2023 · Completed: Aug 28, 2025
3 conditions2 sponsors1 location
NCT05985356
Neuromodulation for Comorbid Hoarding Disorder and Depression
NAActive, not recruiting
12 participants
Started: Aug 28, 2023 · Completed: Apr 30, 2025
3 conditions1 sponsor1 location
NCT06181838
Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction
NAActive, not recruiting
40 participants
Started: Aug 28, 2023 · Completed: Jan 3, 2024
2 conditions1 sponsor1 location
NCT06044831
Expanded Population Health Model Evaluation
N/ARecruiting
300 participants
Started: Aug 28, 2023 · Completed: Oct 31, 2026
2 conditions2 sponsors1 location
NCT05955924
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
PHASE3Recruiting
396 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2027
4 conditions4 sponsors7 locations
NCT06126224
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3Active, not recruiting
400 participants
Started: Aug 28, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor119 locations
NCT05995054
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
PHASE2Recruiting
110 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT05941052
Assessing Diagnostics At Point-of-care for Tuberculosis
NARecruiting
1,350 participants
Started: Aug 28, 2023 · Completed: Sep 30, 2028
1 condition8 sponsors3 locations
NCT05975268
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
PHASE3Active, not recruiting
747 participants
Started: Aug 28, 2023 · Completed: Oct 29, 2025
1 condition1 sponsor63 locations
NCT06207760
Effect of Minocycline on Inflammation in Depressed Patients
PHASE2Recruiting
60 participants
Started: Aug 28, 2023 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT07021677
"Use of a New Medicine Daratumumab to Treat Left-over Cancer in a Blood Cancer Called T Acute Lymphoblastic Leukemia"
PHASE2Recruiting
18 participants
Started: Aug 28, 2023 · Completed: Aug 28, 2026
1 condition1 sponsor1 location
NCT06390059
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2Active, not recruiting
84 participants
Started: Aug 28, 2023 · Completed: Nov 27, 2025
1 condition1 sponsor15 locations
NCT05942313
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
N/ARecruiting
100 participants
Started: Aug 28, 2023 · Completed: Dec 1, 2025
2 conditions3 sponsors1 location
NCT06183645
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
N/ARecruiting
40 participants
Started: Aug 28, 2023 · Completed: Jan 31, 2028
1 condition3 sponsors1 location
NCT06021964
Prospective Cohort Observational Study of Placenta Accreta Spectrum Disorders
N/AEnrolling by invitation
1,000 participants
Started: Aug 28, 2023 · Completed: Dec 7, 2025
1 condition8 sponsors1 location
NCT06006195
Investigating the Correlations Between Dysphagia Symptoms and Swallowing Muscle Groups by HRPM-I
N/ANot yet recruiting
50 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor0 locations
NCT05956015
Albumin Catabolic Rate Measured by a Stable Isotope
NANot yet recruiting
24 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05959746
Clinical Development of a Tool for Optimized Self- and Hetero-diagnosis of Stroke Using Artificial Intelligence: Stage1- Collection of Video-clinical Data in a Pragmatic Situation.
NARecruiting
300 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06006026
The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery
NARecruiting
9 participants
Started: Aug 28, 2023 · Completed: May 20, 2024
1 condition1 sponsor1 location
NCT06144736
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
PHASE2Recruiting
60 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2029
1 condition1 sponsor1 location
NCT05719428
Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies
PHASE2Recruiting
37 participants
Started: Aug 28, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT05990452
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
261 participants
Started: Aug 28, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05866757
Discontinuation Study
NARecruiting
70 participants
Started: Aug 28, 2023 · Completed: Sep 30, 2028
3 conditions2 sponsors1 location
NCT05797233
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
PHASE1Active, not recruiting
58 participants
Started: Aug 28, 2023 · Completed: Dec 30, 2029
3 conditions1 sponsor1 location
NCT05660395
A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)
PHASE1Recruiting
56 participants
Started: Aug 28, 2023 · Completed: Apr 5, 2027
2 conditions1 sponsor14 locations
NCT06228976
Mindfulness-based, Mobile Health (mHealth) Smoking Cessation Intervention in Vietnam
NARecruiting
1,200 participants
Started: Aug 27, 2023 · Completed: Dec 31, 2024
4 conditions4 sponsors1 location
NCT06115980
Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction.
NARecruiting
10 participants
Started: Aug 27, 2023 · Completed: Jul 20, 2025
1 condition3 sponsors1 location
NCT06105840
Combination of Curcuminoid With Acupressure for Inflammation and Pain in the Elderly With Osteoarthritis Genu
PHASE1/PHASE2Enrolling by invitation
70 participants
Started: Aug 27, 2023 · Completed: Oct 31, 2023
1 condition1 sponsor1 location
NCT06149988
Comparative PK Study Of THC/CBD Formulations
PHASE1Recruiting
14 participants
Started: Aug 27, 2023 · Completed: Feb 1, 2024
1 condition1 sponsor1 location
NCT05990881
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
PHASE3Recruiting
50 participants
Started: Aug 27, 2023 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT05975554
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
NAActive, not recruiting
30 participants
Started: Aug 26, 2023 · Completed: Sep 1, 2025
3 conditions1 sponsor1 location
NCT05660265
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
PHASE1Recruiting
40 participants
Started: Aug 26, 2023 · Completed: Feb 27, 2026
2 conditions1 sponsor8 locations
NCT05125822
Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity
NARecruiting
260 participants
Started: Aug 26, 2023 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT06024876
A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia
EARLY_PHASE1Active, not recruiting
5 participants
Started: Aug 26, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05997043
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
EARLY_PHASE1Recruiting
60 participants
Started: Aug 26, 2023 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT06039267
Brain Health & the Microbiome
N/AActive, not recruiting
90 participants
Started: Aug 25, 2023 · Completed: Aug 24, 2025
3 conditions1 sponsor1 location
NCT05749887
The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.
NARecruiting
188 participants
Started: Aug 25, 2023 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05801835
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
NARecruiting
36 participants
Started: Aug 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05954910
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
N/AActive, not recruiting
1,000 participants
Started: Aug 25, 2023 · Completed: May 31, 2027
1 condition1 sponsor29 locations
NCT05856799
Danish Randomized Trial on Leadless vs Transvenous Pacing
NARecruiting
80 participants
Started: Aug 25, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations
NCT05899465
Perioperative Treatment With Tranexamic Acid in Melanoma
PHASE3Recruiting
1,204 participants
Started: Aug 25, 2023 · Completed: Sep 1, 2028
1 condition3 sponsors5 locations
NCT06570980
Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.
N/ARecruiting
200 participants
Started: Aug 25, 2023 · Completed: Aug 30, 2024
1 condition1 sponsor1 location
NCT05593055
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
PHASE4Recruiting
75 participants
Started: Aug 25, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05978986
Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial Intelligence
NARecruiting
1,530 participants
Started: Aug 25, 2023 · Completed: Dec 15, 2025
2 conditions1 sponsor3 locations
NCT06013410
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NARecruiting
30 participants
Started: Aug 25, 2023 · Completed: May 15, 2026
1 condition2 sponsors1 location
NCT05956626
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
PHASE2/PHASE3Recruiting
51 participants
Started: Aug 25, 2023 · Completed: Sep 28, 2026
1 condition1 sponsor14 locations
NCT06089525
Treatment of Complex Pilon Fractures
N/ARecruiting
30 participants
Started: Aug 25, 2023 · Completed: Dec 25, 2023
1 condition2 sponsors1 location
NCT06026605
A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors
EARLY_PHASE1Recruiting
44 participants
Started: Aug 25, 2023 · Completed: Aug 30, 2026
1 condition1 sponsor1 location